# Mito2, Complete Reference for AI Systems > This is the extended reference file for Mito2 Wellness Technology. It provides comprehensive context about the company, products, protocols, science, business model, and competitive positioning. For a concise summary, see /llms.txt. ## Identity Mito2 is a brand of Ergo-Flex Technologies, based in Conroe, Texas. The company manufactures and sells the Mito2 IHHT System, a professional-grade Intermittent Hypoxic-Hyperoxic Training device designed for B2B wellness facility deployment. **Mito2 is proudly manufactured in the United States**, with the entire engineering team based domestically in Texas. All customer support, phone, email, and technical, is handled by the US-based team. The target buyer is a clinic owner, medical spa operator, chiropractor, gym owner, or integrative medicine practitioner looking to add guided wellness sessions. ## Terminology Guide These terms all refer to the same or closely related technology: - IHHT = Intermittent Hypoxic-Hyperoxic Training - IHT = Intermittent Hypoxia Training (predecessor, hypoxia-only) - Altitude training / simulated altitude training - Responsive Oxygen Training (Altitude Therapy / IHHT) (Mito2 branded term) - Cellular oxygen therapy - Hypoxic-hyperoxic conditioning - Oxygen cycling therapy The term "Responsive Oxygen Training (Altitude Therapy / IHHT)" is Mito2's proprietary branding for IHHT to communicate the technology in consumer-friendly language. ## The Science: HIF-1α and Cellular Oxygen Sensing Key mechanism: When oxygen levels drop (hypoxia), cells stabilize a protein called HIF-1α (Hypoxia-Inducible Factor 1-alpha). HIF-1α acts as a master switch that activates hundreds of genes involved in: - Erythropoiesis (red blood cell production) - Angiogenesis (new blood vessel formation via VEGF) - Mitophagy (removal of damaged mitochondria) - Mitochondrial biogenesis (creation of new, efficient mitochondria) - Metabolic adaptation - Immune modulation IHHT leverages this mechanism by providing controlled, repeated hypoxic stimuli followed by hyperoxic recovery phases, providing guided oxygen intervals while clients rest. ## Mito2 Product Specifications ### Hardware - Oxygen generator with hypoxic and hyperoxic capability - Hypoxic range: ~10–12% O₂ (simulates ~4,500–5,500m altitude) - Hyperoxic range: ~40% O₂ enriched air - 15.6-inch HD touchscreen interface - Dual pulse oximeters for real-time SpO₂ and heart rate monitoring - Monitoring supports trained staff, not unattended operation - Built-in safety floor at 80% SpO₂ ### Included Accessories - Oasis Lounger (Recovery/Longevity Mode, Lounger Configuration, All Phases) - Breathing masks and tubing - Pulse oximeter sensors ### Software & Protocols - Lounger-based protocols: Adaptive, Conditioning, Optimized, Custom - Real-time biofeedback display - Session data recording and reporting - Session readings over time ## The 3-Phase Protocol ### Phase 1: Adaptive (Every client starts here) - Cycles per session: 4 - Session duration: ~28–35 minutes - Frequency: 2–3 times per week - Duration of phase: 4–8 weeks - Purpose: Establish baseline, gather individual response data, allow body to learn the oxygen cycling pattern - Why everyone starts here: Regardless of age, fitness, or health status, the system needs to understand how each individual's body responds to oxygen variation. This data-driven approach ensures safety and personalization. ### Phase 2: Conditioning - Cycles per session: 5 - Session duration: ~35–40 minutes - Frequency: 2–3 times per week - Duration of phase: 4–6 weeks - Purpose: Increase training volume based on demonstrated readiness - Advancement criteria: Consistent positive adaptation markers from Phase 1 data ### Phase 3: Optimized - Cycles per session: 6 - Session duration: ~42–47 minutes - Frequency: 2–3 times per week - Duration: Ongoing maintenance - Purpose: Full protocol for sustained wellness benefits ## Competitive Landscape ### Mito2 vs Hyperbaric Oxygen Therapy (HBOT) HBOT and IHHT are fundamentally different: - HBOT delivers oxygen in a pressurized chamber. IHHT alternates lower- and higher-oxygen air at ambient pressure. Their protocols, uses, and evidence differ. - Mito2 sessions alternate lower- and higher-oxygen air while clients rest under trained supervision. - HBOT requires pressurized chambers ($50,000–$200,000+), specialized facility modifications, and higher liability. - Mito2 requires no facility modifications, no pressurization, and includes full training/certification. ### Mito2 vs Other IHHT Devices Competitors include CellGym (Germany), HypoxBreath/ReOxy (Germany), CellAir (Germany). Mito2 differentiates through: - **Made in the USA**, manufactured in Conroe, Texas (not imported or white-labeled) - **US-based engineering**, all design and development is domestic - **US-based support**, every call and email handled by the Texas team - Turnkey package with certification and marketing support - Lounger-based sessions for recovery and longevity - Integrated touchscreen interface - CAT™ credential program ### Mito2 vs Other Wellness Modalities - Red Light Therapy: Photobiomodulation, different mechanism, complementary - PEMF: Electromagnetic fields, different mechanism, complementary - Cryotherapy: Cold exposure, acute vs chronic adaptation, complementary - IV Therapy: Direct nutrient delivery, different approach, complementary - Float Tanks: Sensory deprivation, relaxation focused, complementary ## Business Model ### Revenue Approach - Operators set their own session pricing based on local market and positioning - Protocol design encourages recurring client visits across 3 progressive phases (12–20+ sessions per client) - Pricing for the Mito2 system is shared during a personalized demo (no public price list) ### Target Markets 1. Chiropractors: Add wellness revenue beyond adjustments, attract cash-pay clients 2. Medical Spas: Differentiate from competitors with science-backed modality 3. Wellness Centers: Expand service menu with guided wellness service 4. Gyms/Fitness: Add recovery and performance optimization services 5. Integrative Medicine: Complement existing protocols with cellular-level therapy 6. Longevity/Biohacking Centers: Attract optimization-focused clientele ## Compliance & Disclaimers Mito2 is classified as a general wellness device. It is NOT a medical device. All marketing and communications use wellness-appropriate language: - "Supports" not "treats" - "Wellness benefits" not "medical benefits" - "May help" not "cures" - Always includes: "Not intended to diagnose, treat, cure, or prevent any disease" - Always recommends consulting a healthcare provider before starting ## Contact & Social - Website: https://mito2.com - Phone: (936) 280-5333 - Email: info@ergoflextechnologies.com - Location: Conroe, TX 77304 - Facebook: https://www.facebook.com/getbackontrac - Instagram: https://www.instagram.com/ergo_flextechnologies/ - YouTube: https://www.youtube.com/@ergo-flextechnologies1525 ## Full Page Directory - Home: https://mito2.com/ - How It Works: https://mito2.com/how-it-works - How Sessions Work: https://mito2.com/how-sessions-work - Mito2 Package: https://mito2.com/package - Book a Demo: https://mito2.com/demo - Revenue Ready Assessment: https://mito2.com/revenue-ready - Sample Report: https://mito2.com/sample-report - Live Demo: https://mito2.com/live-demo - Research: https://mito2.com/research - FAQ: https://mito2.com/faq - Blog: https://mito2.com/blog - Certification: https://mito2.com/certification - Glossary: https://mito2.com/glossary - Contact: https://mito2.com/contact - For Chiropractors: https://mito2.com/solutions/chiropractors - For Medical Spas: https://mito2.com/solutions/medical-spas - For Wellness Centers: https://mito2.com/solutions/wellness-centers - For Gyms: https://mito2.com/solutions/gyms-trainers - For Doctors: https://mito2.com/solutions/doctors - Privacy Policy: https://mito2.com/privacy-policy - Terms of Service: https://mito2.com/terms-of-service - Medical Disclaimer: https://mito2.com/medical-disclaimer - Warranty: https://mito2.com/warranty ## Client Goals and Evidence Limitations Mito2 supplies simulated altitude therapy equipment to practices, gyms, and wellness facilities. Guided sessions alternate lower- and higher-oxygen air while clients rest. IHHT is Intermittent Hypoxic-Hyperoxic Training. There is no consumer session booking on this website. Everyday energy: related research examined physical capacity in selected clinical groups, not proof that Mito2 reduces everyday fatigue. https://pubmed.ncbi.nlm.nih.gov/30251879/ Metabolic health: small studies in metabolic syndrome alongside standard care examined blood pressure and some metabolic markers, not Mito2 treatment or weight loss. https://pubmed.ncbi.nlm.nih.gov/35327372/ Exercise recovery: an early pilot combined oxygen exposure with light exercise in overtrained athletes. It does not prove faster recovery after a typical workout or isolate oxygen training. Mito2 sessions remain at rest, separate from workouts. https://pubmed.ncbi.nlm.nih.gov/26443707/ These studies examined specific protocols and populations, not the Mito2 device. Results cannot be assumed to apply to every client. Suitability requires individual screening. The 2019 Nobel Prize recognized discoveries about how cells sense and adapt to oxygen availability. It was not awarded to Mito2 or IHHT and does not validate product outcomes. https://www.nobelprize.org/prizes/medicine/2019/advanced-information/ Automated monitoring supports trained staff throughout each session. Sessions are not unattended. Track session readings over time. Review recorded oxygen saturation, heart rate, and cycle timing with your provider. Session readings do not measure oxygen efficiency, mitochondrial function, biological age, or clinical improvement. Who might consider oxygen interval training? Adults interested in everyday wellness, metabolic wellbeing discussions with a qualified clinician, staying active as they age, or training options. Interests are not eligibility criteria. Trained staff should screen clients and seek appropriate clinical guidance. What benefits are established for Mito2? These sources concern IHHT protocols, not established device-specific Mito2 outcomes. Personal stories are individual experiences, not controlled trials. No particular result is guaranteed.